Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05820646
NA

Effect of Boswellia Sacra as an Intracanal Medicament on Postoperative Pain Intensity and Bacterial Load Reduction

Sponsor: Cairo University

View on ClinicalTrials.gov

Summary

This research will study the effect of Boswellia Sacra versus calcium hydroxide as an intracanal medicament on postoperative pain intensity measured using numerical rating scale (NRS) and bacterial load reduction reduction determined by bacterial counting using agar culture technique after root canal preparation (CFU/ml) in mandibular premolars with necrotic pulp.

Official title: Effect of Boswellia Sacra Versus Calcium Hydroxide as an Intracanal Medicament on Postoperative Pain Intensity and Bacterial Load Reduction in Necrotic Mandibular Premolars: A Randomized Clinical Trial

Key Details

Gender

All

Age Range

25 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2024-05

Completion Date

2024-08

Last Updated

2024-04-12

Healthy Volunteers

Yes

Conditions

Interventions

OTHER

Boswellia Sacra

1. Boswellia Sacra used as an intracanal medicament for 3 days 2. Boswellia Sacra used as an intracanal medicament for 7 days

Locations (1)

Cairo University Hospital ,Endodontic clinic

Giza, Manial, Egypt